Type 2 diabetes mellitus screening rates in racial and ethnic minority groups.
Journal
Journal of the American Association of Nurse Practitioners
ISSN: 2327-6924
Titre abrégé: J Am Assoc Nurse Pract
Pays: United States
ID NLM: 101600770
Informations de publication
Date de publication:
12 01 2022
12 01 2022
Historique:
received:
02
09
2021
accepted:
19
11
2021
pubmed:
14
1
2022
medline:
6
4
2022
entrez:
13
1
2022
Statut:
epublish
Résumé
More than 7 million Americans aged 18 years and older have undiagnosed diabetes. As primary health care moves toward preventative medicine, it is important that diabetes screening deficits are addressed. The purpose of this study was to identify current screening rates among racial and ethnic minorities who are considered at high risk of developing type 2 diabetes mellitus (T2DM). Data were collected through an IRB-approved i2b2 database from previously consented patients who had been treated at a large academic health center and outpatient facilities. Patients who were included in this study were those seen in outpatient settings between June 2011 and June 2019, aged 18-39 years at high risk for developing T2DM, defined as those of a racial and ethnic minority background, obese, and with a family history of T2DM. Approximately 1,476 ± 3 individuals were identified as high risk, and of those, only 106 ± 3 (13.9%) were screened for T2DM between June 2011 and June 2019. Following the American Diabetes Association guidelines of including body mass index ≥25 kg/m2, approximately 1,263 ± 3 of the original 1,476 patients were identified as overweight with high risk, and of those patients, only 90 ± 3 (13.8%) were screened. Findings indicate that less than 14% of patients at high risk for developing T2DM in their lifetime are being screened. Screening strategies need to be developed and implemented to better identify individuals at high risk of developing T2DM, which may lead to earlier diagnosis, treatment, and decreased disease burden.
Sections du résumé
BACKGROUND
More than 7 million Americans aged 18 years and older have undiagnosed diabetes. As primary health care moves toward preventative medicine, it is important that diabetes screening deficits are addressed.
PURPOSE
The purpose of this study was to identify current screening rates among racial and ethnic minorities who are considered at high risk of developing type 2 diabetes mellitus (T2DM).
METHODOLOGY
Data were collected through an IRB-approved i2b2 database from previously consented patients who had been treated at a large academic health center and outpatient facilities. Patients who were included in this study were those seen in outpatient settings between June 2011 and June 2019, aged 18-39 years at high risk for developing T2DM, defined as those of a racial and ethnic minority background, obese, and with a family history of T2DM.
RESULTS
Approximately 1,476 ± 3 individuals were identified as high risk, and of those, only 106 ± 3 (13.9%) were screened for T2DM between June 2011 and June 2019. Following the American Diabetes Association guidelines of including body mass index ≥25 kg/m2, approximately 1,263 ± 3 of the original 1,476 patients were identified as overweight with high risk, and of those patients, only 90 ± 3 (13.8%) were screened.
CONCLUSIONS
Findings indicate that less than 14% of patients at high risk for developing T2DM in their lifetime are being screened.
IMPLEMENTATIONS
Screening strategies need to be developed and implemented to better identify individuals at high risk of developing T2DM, which may lead to earlier diagnosis, treatment, and decreased disease burden.
Identifiants
pubmed: 35025836
doi: 10.1097/JXX.0000000000000687
pii: 01741002-202204000-00012
doi:
Types de publication
Journal Article
Langues
eng
Pagination
683-687Informations de copyright
Copyright © 2022 American Association of Nurse Practitioners.
Déclaration de conflit d'intérêts
Competing interests: The authors report no conflicts of interest.
Références
Bancks M. P., Kershaw K., Carson A. P., Gordon-Larsen P., Schreiner P. J., Carnethon M. R. (2017). Association of modifiable risk factors in young adulthood with racial disparity in incident type 2 diabetes during middle adulthood. JAMA, 318(24), 2457–2465. doi: 10.1001/jama.2017.19546 .
doi: 10.1001/jama.2017.19546
Campbell J. A., Walker R. J., Smalls B. L., Egede L. E. (2012). Glucose control in diabetes: The impact of racial differences on monitoring and outcomes. Endocrine, 42(3), 471–482. doi: 10.1007/s12020-012-9744-6 .
doi: 10.1007/s12020-012-9744-6
Centers for Disease Control and Prevention. (2020). National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services. Retrieved. August 3, 2021. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf .
Cowie C. C. (2019). Diabetes diagnosis and control: Missed opportunities to improve health. Diabetes Care, 42(6), 994–1004. doi: 10.2337/dci18-0047 .
doi: 10.2337/dci18-0047
Forouhi N. G., Wareham N. J. (2014). The EPIC-InterAct study: A study of the interplay between genetic and lifestyle behavioral factors on the risk of type 2 diabetes in European populations. Current Nutrition Reports, 3(4), 355–363. doi: 10.1007/s13668-014-0098-y .
doi: 10.1007/s13668-014-0098-y
Hafez D., Nelson D. B., Martin E. G., Cohen A. J., Northway R., Kullgren J. T. (2017). Understanding type 2 diabetes mellitus screening practices among primary care physicians: A qualitative chart-stimulated recall study. BMC Family Practice, 18(1), 50. doi: 10.1186/s12875-017-0623-3 .
doi: 10.1186/s12875-017-0623-3
Jeansen E. T., Dabelea (2018). Type 2 diabetes in youth: New lessons from the SEARCH study. Current Diabetes Report, 18(6), 36. doi: 10.1007/s11892-018-0997-1 .
doi: 10.1007/s11892-018-0997-1
McCulloch D. K., MD, Robertson P., MD. (2018). Prevention of type 2 diabetes mellitus. Retrieved February 11, 2018, from https://www.uptodate.com/contents/prevention-of-type-2-diabetes-mellitus .
O'Brien M. J., Young Lee J., Carnethon M. R., Ackermann R. T., Vargas M. C., Hamilton A., Mohanty N., Rittner S. S., Park J. N., Hassan A., Buchanan D. R., Liu L., Feinglass J. (2016). Preventive services task force screening criteria: A cohort analysis of community health center patients. PLoS Medicine. doi: 10.1371/journal.pmed.1002074 .
doi: 10.1371/journal.pmed.1002074
Sami W, Ansari T, Butt NS, Hamid MRA. Effect of diet on type 2 diabetes mellitus: A review. Int J health Sci (Qassim). 2017;11(2):65–71.
Sheehy A., Pandhi N., Coursin D., Flood G. E., Kraft S. A., Johnson H. M., Smith M. A. (2011). Minority status and diabetes screening in an ambulatory population. Diabetes Care, 34(6), 1289–1294. doi: 10.2337/dc10-1785 .
doi: 10.2337/dc10-1785
Siu A. L. (2015). Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 163(11), 861–868. doi: 10.7326/M15-2345 .
doi: 10.7326/M15-2345
Tung E. L., Baig A. A., Huang E. S., Laiteerapong N., Chua K. P. (2017). Racial and ethnic disparities in diabetes screening between Asian Americans and other adults: BRFSS 2012-2014. Journal of General Internal Medicine, 32(4), 423–429. doi: 10.1007/s11606-016-3913-x .
doi: 10.1007/s11606-016-3913-x